Search Results 441-450 of 17833 for Coagulate

1. Use of endoscopic submucosal dissection for treatment of gastrointestinal lesions - Mayo Clinic

   ... Large, biopsy-proven, flat dysplastic lesion marked by coagulation dots. Endoscopic submucosal ...

2. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

   ... coagulation, immunological, endocrine/metabolic, neurologic, oncologic, or other medical disorder developed during or after participation in a prior ...

3. Barrett's Esophagus Clinical Trials

   The purpose of this study is to investigate if Hybrid Argon Plasma Coagulation (HAPC) is non-inferior to Radiofrequency Ablation (RFA) in the stricture-free ...

4. PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL) (PACIFICA) - Mayo Clinic

   Adequate coagulation function, defined by prothrombin time (PT)/international normalized ratio (INR), international normalized ration (INR) and partial ...

5. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

   ... coagulating agents for at least 6 weeks are eligible; Receiving any other investigational agent which would be considered as a treatment for the primary ...

6. Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma - Mayo Clinic

   ... coagulation studies (INR/PTT) and platelet counts suitable for surgery per surgeon discretion. Exclusion Criteria: -Second primary malignancy -History of ...

7. Open-Label extension study of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis - Mayo Clinic

   History of intracranial hemorrhage, arteriovenous malformation, bleeding disorder, and coagulation disorders. An uncontrolled thyroid disorder. Uncontrolled ...

8. Barrett's Esophagus Clinical Trials

   The purpose of this study is to investigate if Hybrid Argon Plasma Coagulation (HAPC) is non-inferior to Radiofrequency Ablation (RFA) in the stricture-free ...

9. A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery - Mayo Clinic

   - Pre-existing coagulation factor deficiency: including, but not limited to. fibrinogen < 2.5-2.8 g/L - Any emergency surgeries performed less than 30 days ...

10. A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

    Coagulation parameters: International normalised ratio (INR) >2, prolongation of prothrombin time (PT) and partial thromboplastin time (PTT) by >1.5 x ULN ...